[Congressional Record Volume 160, Number 81 (Wednesday, May 28, 2014)]
[Extensions of Remarks]
[Page E853]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     HONORING DR. MICHAEL SEVERINO

                                 ______
                                 

                          HON. PETER J. ROSKAM

                              of illinois

                    in the house of representatives

                        Wednesday, May 28, 2014

  Mr. ROSKAM. Mr. Speaker, I rise today to recognize Michael Severino, 
M.D., an outstanding physician from Illinois. Recently, AbbVie, a 
cutting-edge pharmaceutical company with a large Illinois presence, 
named Dr. Severino Executive Vice President of Research and Development 
(R&D) and Chief Scientific Officer. AbbVie's selection of Dr. Severino 
to lead corporate innovation and product development reflects a 
company-wide commitment to developing new therapies and continuing to 
push the bio-tech industry to new frontiers.
  Dr. Severino's responsibilities will include leading AbbVie's R&D, 
Medical Affairs and Regulatory Affairs organizations, bringing his 
years of experience to bear on guiding the company's 7,000 worldwide 
employees engaged in scientific discovery. Collectively, they will be 
working to develop a steady stream of new medicines for patients.
  Dr. Severino has most recently served as Senior Vice President and 
Chief Medical Officer at AbbVie. He is a leader in clinical development 
strategy across therapeutic areas including immunology, neuroscience, 
oncology and cardiovascular disease. Over ten years at AbbVie, Dr. 
Severino has consistently taken on positions of increasing 
responsibility, particularly in the area of R&D.
  AbbVie's Chairman and Chief Executive Officer, Michael Gonzalez, 
praised Dr. Severino stating, ``We are fortunate to have a leader of 
his caliber to steer our efforts to develop treatments for today's 
toughest health challenges. He will be instrumental in moving our 
pipeline and strategy forward.''
  Mr. Speaker, and my distinguished colleagues in the House, please 
join me in congratulating Dr. Severino on his new position and wishing 
him many future successes as he works to understand and treat a wide 
array of ailments to help others live happier, healthier lives.

                          ____________________